K. Lin

发表

Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.

S. Jiang, A. Neurath, N. Strick, 1995, AIDS research and human retroviruses.

Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41 [published erratum appears in J Exp Med 1992 Feb 1;175(2):621]

S. Jiang, A. Neurath, K. Lin, 1991, The Journal of experimental medicine.

Glycodelins GdA and GdS modified by 3-hydroxyphthalic anhydride inhibit gp120-CD4 binding and HIV-1 infection in vitro.

H. Koistinen, R. Koistinen, M. Seppälä, 1997, Laboratory investigation; a journal of technical methods and pathology.

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine

Fei Liu, W. Jia, Xiaoming Yang, 2022, bioRxiv.

Two partially overlapping antiviral peptides from the external portion of HIV type 1 glycoprotein 41, adjoining the transmembrane region, affect the glycoprotein 41 fusion domain.

S. Jiang, A. Neurath, N. Strick, 1995, AIDS research and human retroviruses.

Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence.

S. Jiang, K. Lin, S. Jiang, 1995, Peptide research.

Chemically modified bovine beta-lactoglobulin blocks uptake of HIV-1 by colon- and cervix-derived epithelial cell lines.

S. Jiang, A. Neurath, N. Strick, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.

Shibo Jiang, S. Jiang, A. Neurath, 1999, Biologicals : journal of the International Association of Biological Standardization.

A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody.

A. Debnath, S. Jiang, K. Lin, 1999, Journal of virological methods.

Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41.

S. Jiang, A. Neurath, N. Strick, 1993, Biochemical and biophysical research communications.

A comprehensive overview on the transmission, pathogenesis, diagnosis, treatment, and prevention of SARS‐CoV‐2

Xin Wang, Linding Wang, K. Lin, 2023, Journal of medical virology.

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1.

A. Debnath, S. Jiang, A. Neurath, 1994, Journal of medicinal chemistry.

Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV‐1) by chemically modified bovine milk proteins: Potential for AIDS prophylaxis

A. Debnath, Shibo Jiang, A. Neurath, 1995, Journal of molecular recognition : JMR.

3-Hydroxyphthaloyl-β-Lactoglobulin. II. Anti-Human Immunodeficiency Virus Type 1 Activity in in Vitro Environments Relevant to Prevention of Sexual Transmission of the Virus

A. Debnath, Shibo Jiang, A. Neurath, 1997 .

3-Hydroxyphthaloyl-β-Lactoglobulin. I. Optimization of Production and Comparison with other Compounds Considered for Chemoprophylaxis of Mucosally Transmitted Human Immunodeficiency Virus Type 1

A. Debnath, Shibo Jiang, A. Neurath, 1997 .